Rantum Capital provided a senior secured term loan for the acquisition of pharmaceuticals company Lyocontract GmbH by financial investor Great Point Partners. The loan provided through Rantum Private Debt Fund III serves as part of the purchase price financing for the acquisition of a majority stake in Lyocontract.

Lyocontract is a leading niche pharmaceuticals company, providing contract manufacturing services for pharmaceutical products and biotechnological drugs. The company is headquartered in Ilsenburg (Saxony-Anhalt) and specializes in services in the field of lyophilization, also known as freeze-drying. Lyophilization is a process for drying sensitive pharmaceutical and biotechnological products, where water is removed from the product at low temperatures to enhance stability and shelf life.

Florian Feder, Managing Director at Rantum Capital, comments: “In addition to the focus on a structurally growing market, we were impressed by the attractive margin profile,the stable customer relationships, and the the highly experienced management, which convinced us to invest in this company.”

Rantum Capital was legally advised on the transaction by the law firm Goodwin Procter LLP (Winfried Carli und Marius Garnatz).

Auf dieser Website werden Cookie verwendet. Diese werden für den Betrieb der Website benötigt oder helfen uns dabei, die Website zu verbessern.
Alle Cookies zulassen
Auswahl speichern
Individuelle Einstellungen
Individuelle Einstellungen
Dies ist eine Übersicht aller Cookies, die auf der Website verwendet werden. Sie haben die Möglichkeit, individuelle Cookie-Einstellungen vorzunehmen. Geben Sie einzelnen Cookies oder ganzen Gruppen Ihre Einwilligung. Essentielle Cookies lassen sich nicht deaktivieren.
Essenziell (1)
Essenzielle Cookies werden für die grundlegende Funktionalität der Website benötigt.
Cookies anzeigen